Cargando…
Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population
BACKGROUND: Shared decision-making (SDM), the process of engaging patients in their healthcare decisions, is an integral component of personalized medicine. The use of SDM in real-world allergy and asthma care in the United States (US) is unknown. Cross-sectional surveys of allergists and patients i...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582489/ https://www.ncbi.nlm.nih.gov/pubmed/37859758 http://dx.doi.org/10.1016/j.waojou.2023.100828 |
_version_ | 1785122343124729856 |
---|---|
author | Eghrari-Sabet, Jacqueline Williams, Dennis Bukstein, Don A. Winders, Tonya Gardner, Donna D. |
author_facet | Eghrari-Sabet, Jacqueline Williams, Dennis Bukstein, Don A. Winders, Tonya Gardner, Donna D. |
author_sort | Eghrari-Sabet, Jacqueline |
collection | PubMed |
description | BACKGROUND: Shared decision-making (SDM), the process of engaging patients in their healthcare decisions, is an integral component of personalized medicine. The use of SDM in real-world allergy and asthma care in the United States (US) is unknown. Cross-sectional surveys of allergists and patients in a US population were conducted to assess the use and perceptions of SDM and SDM tools in real-world allergy and asthma care. METHODS: Allergists (N = 101) who were members of the American College of Allergy Asthma & Immunology (ACAAI) and who were also Dynata (a marketing research firm) research partners or in the Allergy & Asthma Network customer database completed an online survey from February–March 2022. Adult patients (N = 110) with asthma, allergy, and/or eczema in the United States who were participants of online research panels hosted by Dynata completed on online survey from February 1–7, 2022. RESULTS: Based on their own definition, 98% of the allergists reported familiarity with SDM, and 79% reported using it frequently. Allergists reported using SDM with an average of 44% of their patients. The most commonly used tool was the Immunotherapy SDM toolkit (40%); 43% had not used any SDM tool. Among allergists not using SDM or using it infrequently (n = 19), 42% considered it too time-consuming and 37% believed their patients have low health literacy. Of the surveyed patients, 25% reported their provider used SDM “frequently” or “occasionally” when being treated for allergies, asthma, or eczema, and 22% reported using SDM tools with their provider at some point. The most commonly used tool was the Asthma and Allergy Symptom Test (60%). Among patients whose allergists used SDM infrequently or never (n = 56), 70% reported they would be likely to ask their allergist to use SDM more often. CONCLUSION: Survey responses revealed a disconnect between allergists and patients regarding SDM use. Barriers to SDM are consistent with those across the healthcare industry. Patients clearly expressed their desire for SDM. |
format | Online Article Text |
id | pubmed-10582489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | World Allergy Organization |
record_format | MEDLINE/PubMed |
spelling | pubmed-105824892023-10-19 Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population Eghrari-Sabet, Jacqueline Williams, Dennis Bukstein, Don A. Winders, Tonya Gardner, Donna D. World Allergy Organ J Full Length Article BACKGROUND: Shared decision-making (SDM), the process of engaging patients in their healthcare decisions, is an integral component of personalized medicine. The use of SDM in real-world allergy and asthma care in the United States (US) is unknown. Cross-sectional surveys of allergists and patients in a US population were conducted to assess the use and perceptions of SDM and SDM tools in real-world allergy and asthma care. METHODS: Allergists (N = 101) who were members of the American College of Allergy Asthma & Immunology (ACAAI) and who were also Dynata (a marketing research firm) research partners or in the Allergy & Asthma Network customer database completed an online survey from February–March 2022. Adult patients (N = 110) with asthma, allergy, and/or eczema in the United States who were participants of online research panels hosted by Dynata completed on online survey from February 1–7, 2022. RESULTS: Based on their own definition, 98% of the allergists reported familiarity with SDM, and 79% reported using it frequently. Allergists reported using SDM with an average of 44% of their patients. The most commonly used tool was the Immunotherapy SDM toolkit (40%); 43% had not used any SDM tool. Among allergists not using SDM or using it infrequently (n = 19), 42% considered it too time-consuming and 37% believed their patients have low health literacy. Of the surveyed patients, 25% reported their provider used SDM “frequently” or “occasionally” when being treated for allergies, asthma, or eczema, and 22% reported using SDM tools with their provider at some point. The most commonly used tool was the Asthma and Allergy Symptom Test (60%). Among patients whose allergists used SDM infrequently or never (n = 56), 70% reported they would be likely to ask their allergist to use SDM more often. CONCLUSION: Survey responses revealed a disconnect between allergists and patients regarding SDM use. Barriers to SDM are consistent with those across the healthcare industry. Patients clearly expressed their desire for SDM. World Allergy Organization 2023-10-10 /pmc/articles/PMC10582489/ /pubmed/37859758 http://dx.doi.org/10.1016/j.waojou.2023.100828 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Full Length Article Eghrari-Sabet, Jacqueline Williams, Dennis Bukstein, Don A. Winders, Tonya Gardner, Donna D. Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population |
title | Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population |
title_full | Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population |
title_fullStr | Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population |
title_full_unstemmed | Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population |
title_short | Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population |
title_sort | real-world use and perceptions of shared decision-making for allergy and asthma care in a us population |
topic | Full Length Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582489/ https://www.ncbi.nlm.nih.gov/pubmed/37859758 http://dx.doi.org/10.1016/j.waojou.2023.100828 |
work_keys_str_mv | AT eghrarisabetjacqueline realworlduseandperceptionsofshareddecisionmakingforallergyandasthmacareinauspopulation AT williamsdennis realworlduseandperceptionsofshareddecisionmakingforallergyandasthmacareinauspopulation AT buksteindona realworlduseandperceptionsofshareddecisionmakingforallergyandasthmacareinauspopulation AT winderstonya realworlduseandperceptionsofshareddecisionmakingforallergyandasthmacareinauspopulation AT gardnerdonnad realworlduseandperceptionsofshareddecisionmakingforallergyandasthmacareinauspopulation |